Intracranial hemorrhage management in the multi-omics era

Area of Science:

• Neuroscience
• Genomics
• Proteomics
• Metabolomics
• Microbiome Research

Background:

• Intracranial hemorrhage (ICH) is a severe neurological disorder with limited effective treatments.
• Neuroprotective strategies show promise in animal models but yield disappointing clinical trial results.
• The need for novel therapeutic approaches in ICH management is critical.

Purpose of the Study:

• To review the applications of multi-omics data in understanding Intracranial Hemorrhage (ICH).
• To highlight the advantages of integrating genomics, transcriptomics, epigenetics, proteomics, metabolomics, and microbiome data for ICH.
• To underscore the importance of multi-omics approaches for advancing precision medicine in ICH.

Main Methods:

• Systematic literature review of omics studies related to ICH.
• Analysis of data from genomics, transcriptomics, epigenetics, proteomics, metabolomics, and gut microbiome research.
• Synthesis of findings to evaluate the utility of multi-omics in ICH.

Main Results:

• Omics technologies offer a comprehensive view of ICH pathophysiology.
• Integration of diverse omics data can identify novel biomarkers and therapeutic targets.
• Multi-omics approaches have the potential to improve patient stratification and treatment efficacy.

Conclusions:

• Multi-omics data integration is essential for advancing precision medicine in Intracranial Hemorrhage.
• Systematic analysis of multi-omics data is crucial for developing effective ICH therapies.
• Future research should focus on translating multi-omics findings into clinical applications for ICH.